Our new Multispecialty Care vertical allows us to introduce focused specialty programs to address the most critical healthcare needs of our patient populations.

Danish Nagda named as one of the region's top business leaders

The FDA has officially declared an end to the supply squeeze on Novo Nordisk's GLP-1 semaglutide, which is also branded as Ozempic and Wegovy.

When we first evaluated our hybrid care model, our first goal was to maintain high quality care without the doctor in the room.

Rising healthcare costs could force employers to rethink salary or wage increases.

It could be a game-changer in addressing some of healthcare's most persistent challenges: cost, access, and quality of care.

Behind salary, health benefits remain the second most important reason people choose where to work.

We’re pleased to announce our partnership with TrueClaim, the world’s first AI-driven TPA.

The 2024 National Alliance of Healthcare Purchaser Coalitions Annual Forum made the case for meaningful change.

At the core, Forward’s fatal error was in the fundamental assumption behind their business model: that people could be taken out of the equation in healthcare.

2024 has seen significant shifts start to take hold of the healthcare benefits landscape.

The cost of healthcare has grown up to 12% annually for the last decade, reaching a total cost of $3.3 trillion in the US in 2020.

This year’s report reveals transformative change — driven by bold leaders, innovative strategies, and a willingness to challenge the status quo.

We’ve closed a $10M Series A round to fuel a new way to care for patients and their families.

Benjamin Wilson will help Rezilient build the infrastructure required to scale our services offering nationwide.